Red Violet Details $30M Share Repurchase Program and Performance-Based Executive RSU Grants in Definitive Proxy
RDVT sits 23% above its 52-week low of $33.4.
Summary
Red Violet filed its definitive proxy statement, outlining proposals for its annual meeting, detailing a $30 million share repurchase program, and disclosing significant performance-based RSU grants to executives.
Key Events · Corporate Governance and Compliance · RDVT
-
Share Repurchase Program Expanded
The Board authorized an additional $15.0 million for share repurchases on November 3, 2025, increasing the total program authorization to $30.0 million. This program represents approximately 5.2% of the company's current market capitalization.
-
Significant Performance-Based RSU Grants
Key executives, including the CEO, President, and CFO, received an aggregate of 832,690 performance-based RSUs on January 9, 2026, with a grant-date fair value of $52.77 per share, totaling approximately $43.9 million. These awards vest upon achieving specified revenue and adjusted EBITDA margin targets.
-
Annual Shareholder Meeting Details
The company will hold its Annual Meeting of Stockholders on June 3, 2026, to vote on the election of five directors, ratification of Grant Thornton LLP as the independent accounting firm, and a non-binding advisory vote on executive compensation.
Analysis · RDVT · Technology
This definitive proxy statement provides comprehensive details on Red Violet's upcoming annual meeting proposals, executive compensation, and an expanded share repurchase program. The company authorized an additional $15.0 million for share repurchases on November 3, 2025, increasing the total program authorization to $30.0 million. This significant capital allocation strategy, representing over 5% of the current market capitalization, signals management's confidence and commitment to shareholder returns. Additionally, the filing details substantial performance-based RSU grants to key executives, valued at approximately $43.9 million, which are designed to align executive incentives with long-term company performance. These disclosures add material specifics to previously indicated corporate actions.
How filings like this one have moved
In the 30 days to Sep 14, 2026, 29.9% of the 1591 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was -0.24%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, RDVT was trading at $40.99 on NASDAQ in the Technology sector, with a market capitalization of approximately $578.1M. The 52-week trading range was $33.40 to $64.14. This filing was assessed with neutral market sentiment and an importance score of 7 out of 10.